Molecular Diagnostics

Buying guide

Because this setup spans several categories rather than one, the price band is wider than any single bench would show. Across the work prices run from EUR 1 to EUR 533.942. The low end is reagents, small consumables and simple preparation accessories, the kind of item a lab reorders without a second thought. The upper end belongs to the amplification and sequencing cores: a high-throughput sequencer or an automated handling platform is where the capital sits, because those instruments carry the optics, the fluidics and the control systems that the rest of the chain feeds. A real-time PCR instrument lands between the two, more than a plain cycler and well short of a sequencer.

Condition is the other axis. 96 percent of the listings are used. For a lab building out this setup, that share is where the capital equipment becomes reachable, since a used sequencer or handler is priced below its new equivalent and a diagnostic workflow does not need every instrument fresh from the line. Used and refurbished units are listed at lower prices than new; that price gap is the clearest reason to weigh one against the other. Where a specific listing matters to a buyer, a warranty can be arranged in consultation for that listing, and parts can be sourced through Questpair. The sensible way to read the band is by stage: match the spend to where it does the work, and the preparation front end rarely justifies the budget that the amplification and sequencing cores do.

Types of Molecular Diagnostics

Molecular diagnostics draws on thermal cyclers, real-time PCR instruments, sequencers, automated liquid handlers and sample-preparation systems, and it runs as a sequence rather than a single bench task. What follows walks that sequence in the order a lab actually performs it, and names the equipment each stage leans on.

How is the sample prepared before anything can be read?

Extraction comes first, and everything downstream inherits its quality. The step isolates nucleic acid from blood, tissue or a swab and strips away the proteins, salts and inhibitors that would otherwise stall an enzyme later. Sample-preparation systems and the reagents around them carry this, and where throughput climbs the work moves onto an automated liquid handler that pipettes extraction plates without a technician touching each well. The constraint runs forward: an eluate carrying residual inhibitor will amplify poorly no matter how good the cycler is, so a lab that under-equips here pays for it two stations later. Yield matters as much as purity, because a low-copy target lost in preparation cannot be recovered by any amount of amplification.

Amplifying and detecting the target

With clean template in hand the assay amplifies a chosen region, and this is where most routine diagnostics live. A thermal cycler drives the denaturation, annealing and extension steps that double the target each round, and its block uniformity decides whether every well of a plate reaches the same endpoint. Real-time PCR instruments fold detection into that cycle, reading a fluorescent signal as the product accumulates so the result is quantitative rather than a yes or no at the end. The two constrain each other with preparation: a quantitative readout is only trustworthy if the input was clean and measured, which is why the handler, the extraction chemistry and the cycler are specified together rather than bought piecemeal.

When does the work move to sequencing?

Where the question is not how much of a known target is present but what the sequence actually is, the assay moves onto a DNA sequencer. This covers variant calling, pathogen identification without a predefined probe, and panels too broad for a single PCR well. High-throughput sequencers sit at the demanding end of this work, and they lean hardest on the preparation and handling stations before them, because a library built unevenly reads unevenly. Genome-editing and molecular tools sit alongside sequencing in the research-facing part of this field, used to construct and verify the constructs an assay later interrogates.

Reading and confirming the result

The final stages confirm and record. Molecular imaging devices visualise gels and labelled products where a run needs a physical readout, and clinical laboratory equipment covers the broader bench that a diagnostic lab runs around these cores. Among the listings that specify a category, the spine of this work is the preparation, amplification and sequencing group, and each depends on the one before it.